BOLD-100 in Combination With FOLFOX for the Treatment of Advanced Solid Tumours
Clinical trial NCT04421820 · RECRUITING
Trial details
- NCT number
- NCT04421820
- Sponsor
- Bold Therapeutics, Inc.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-28
- Primary completion
- 2026-06-01
- Enrollment
- 220
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.